MOUNT LAUREL, N.J., May 3 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ), the leading national provider of medical transcription outsourcing and clinical documentation workflow solutions, announces the release of version 1.1 of its voice capture platform, DocQment(TM) Ovation. This latest software release gives HIM professionals superior management of their medical documentation when using outsourced transcription service providers.

"Ovation has been very successful for us thus far. We signed 20 customers within the first six months of launching this Web-based, enterprise digital voice capture and transport solution last year. As they complete their implementations, customers are experiencing improved turnaround times with new workflow tools such as Quality Control and ADT backfill. Version 1.1 will add to these capabilities with enhanced reporting capabilities and management options that will help provide better control of the document from dictation through signature," says Scott Bennett, MedQuist senior vice president of Sales and Marketing.

"Outsourcing is a valuable resource for healthcare providers," adds Emmy Weber, MedQuist vice president of Product Management, "and our customers have indicated the need for more advanced work management tools in order to effectively manage multiple outsourcing vendors as well as internal transcriptionists." Ovation version 1.1 addresses these needs at the point of dictation and is specifically engineered to tightly integrate with MedQuist's dictation, speech recognition and transcription platform while interfacing smoothly with other outsourcing vendors.

Key enhancements with version 1.1 include: -- New reporting capabilities; -- Improved QA/QC controls and workflow options; -- Enhanced functionality of the Ovation Enterprise Workstation; -- A Quick View of document lists; and -- Streamlined dashboard view to manage users, voice files and documents.

According to Jennifer Busby, HIM director at Maury Regional Healthcare System in Columbia, Tenn., "DocQment Ovation makes us better managers because it enables us to use the information we have more effectively. DocQment Ovation, with the ability to capture patient ADT information, allows a front- end quality control process that streamlines the entire document workflow. This also improves the overall accuracy of the upload to our HIS system. Our MT productivity has increased approximately 18 percent, allowing the MTs to focus on transcription. Overall, we can see where we have overflow, or in some cases, underused capacity. Now we can shift resources to the highest need areas more quickly, without disruption to our system of care."

For more information, contact a local MedQuist representative or dial 1-800-233-3030 for sales assistance.

MedQuist, a member of the Philips Group of Companies, is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, and health information and document management products and services, including digital dictation, speech recognition, Web-based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such risks and uncertainties, which could cause actual results to differ from those contained in forward-looking statements include, but are not limited to: (1) our ability to recruit and retain qualified transcriptionists and other employees; (2) the impact of new services or products on the demand for our existing services; (3) our current dependence on medical transcription for substantially all of our business; (4) our ability to expand our customer base; (5) changes in law, including, without limitation, the impact the Health Insurance Portability and Accountability Act (HIPAA) will have on our business; (6) infringement on the proprietary rights of others; (7) risks inherent in diversifying into other businesses; (8) any continuation of pricing pressures and declining billing rates; (9) difficulties relating to the implementation of management changes throughout the Company; (10) the outcome of pending and future legal and regulatory proceedings and investigations; and (11) any direct or indirect impact of the matters disclosed in the Form 8-K filed by the Company on March 19, 2007. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward- looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Kathleen Lang, Marketing Communications of MedQuist Inc.,
+1-856-206-4725, klang@medquist.com

Web site: http://www.medquist.com/